Clinical Trials
3 trialsNCT06369259 2026-05-20
Open-label Phase 2 Study of Avutometinib (RAF/MEK Clamp) in Combination With Defactinib (FAK Inhibitor) and Cetuximab in Patients With Unresectable, Anti-EGFR-Refractory Advanced Colorectal Cancer
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT07558083 2026-04-30
FOLICOLOR
University Hospital, Antwerp
Phase 3 Recruiting
NCT03699111 2026-04-13
COLOSSUS
Cancer Trials Ireland
Completed